
RT-GLP3 RETA
10 mg
Certificate of Analysis available for every batch.
Purity ≥99%
Metabolic Optimization Infrastructure.
Made in Canada
$134.99 CAD
Download COAAll products sold by PRTCL are intended for laboratory research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
RT-GLP3 is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously.
Frequently Purchased Together
Structured protocols perform best within systems.
These compounds are commonly selected together.
1 of 3 selected
Protocol Classification
Structured Transparency.
Every PRTCL. unit includes:
- Third-party lab testing
- Downloadable Certificate of Analysis
- Controlled labeling format
- Standardized packaging architecture
Built on Protocol.

